360 related articles for article (PubMed ID: 16081212)
1. The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin.
Yoo YM; Kim YJ; Lee U
Neurosci Lett; 2005 Oct; 387(2):100-4. PubMed ID: 16081212
[TBL] [Abstract][Full Text] [Related]
2. Injuring neurons induces neuronal differentiation in a population of hippocampal precursor cells in culture.
Tseng HC; Ruegg SJ; Maronski M; Messam CA; Grinspan JB; Dichter MA
Neurobiol Dis; 2006 Apr; 22(1):88-97. PubMed ID: 16330214
[TBL] [Abstract][Full Text] [Related]
3. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
[TBL] [Abstract][Full Text] [Related]
5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
7. Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells.
Maciaczyk J; Singec I; Maciaczyk D; Nikkhah G
Exp Neurol; 2008 Oct; 213(2):354-62. PubMed ID: 18652826
[TBL] [Abstract][Full Text] [Related]
8. Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis.
Nitta A; Nishioka H; Fukumitsu H; Furukawa Y; Sugiura H; Shen L; Furukawa S
J Neurosci Res; 2004 Oct; 78(2):250-8. PubMed ID: 15378610
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines.
Ling ZD; Potter ED; Lipton JW; Carvey PM
Exp Neurol; 1998 Feb; 149(2):411-23. PubMed ID: 9500954
[TBL] [Abstract][Full Text] [Related]
10. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R
Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.
Widmer HR; Schaller B; Meyer M; Seiler RW
Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
13. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
Ebert AD; Beres AJ; Barber AE; Svendsen CN
Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
[TBL] [Abstract][Full Text] [Related]
14. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells.
Storch A; Paul G; Csete M; Boehm BO; Carvey PM; Kupsch A; Schwarz J
Exp Neurol; 2001 Aug; 170(2):317-25. PubMed ID: 11476598
[TBL] [Abstract][Full Text] [Related]
15. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
[TBL] [Abstract][Full Text] [Related]
16. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
17. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
[TBL] [Abstract][Full Text] [Related]
19. GDNF promotes neuronal differentiation and dopaminergic development of mouse mesencephalic neurospheres.
Roussa E; Krieglstein K
Neurosci Lett; 2004 May; 361(1-3):52-5. PubMed ID: 15135891
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]